| Abstract | Most cytotoxic chemotherapy protocols used in small animals are designed to have a low risk of adverse effects; however, adverse events can occasionally occur. Timely and appropriate management of adverse events greatly increases client satisfaction and the likelihood of a successful treatment outcome. This article presents guidelines for the management of chemotherapy-associated hematological and gastrointestinal disturbances, extravasation injury, and anaphylaxis. |
| Authors | Douglas H Thamm, David M Vail
(Affiliation: The Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA.)
|
| Journal | Journal of the American Animal Hospital Association
(J Am Anim Hosp Assoc)
2007 Jan-Feb
Vol. 43
Issue 1
Pg. 1-7
ISSN: 1547-3317 United States |
| PMID | 17209078
(Publication Type: Journal Article, Review)
|
| Chemical References |
|
| Topics |
- Anaphylaxis
(chemically induced, prevention & control, veterinary)
- Animals
- Antineoplastic Agents
(adverse effects)
- Cat Diseases
(chemically induced, prevention & control, therapy)
- Cats
- Dog Diseases
(chemically induced, prevention & control, therapy)
- Dogs
- Drug Toxicity
(genetics, veterinary)
- Female
- Gastrointestinal Diseases
(chemically induced, therapy, veterinary)
- Male
- Necrosis
(chemically induced, prevention & control, veterinary)
- Neoplasms
(drug therapy, veterinary)
- Neutropenia
(chemically induced, drug therapy, veterinary)
- Practice Guidelines as Topic
- Sepsis
(chemically induced, drug therapy, veterinary)
|
